BRIACELL THERAPEUTICS CORP. Proceeds from Grantors
BRIACELL THERAPEUTICS CORP. (BCTX) reported Proceeds from Grantors of $110.20 thousand for the 3-month period ending 2026-04-30, per its 10-Q filed 2026-06-09.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromGrantors · last filed 2026-06-09
- BRIACELL THERAPEUTICS CORP. proceeds from grantors for the quarter ending 2026-04-30 was $110.20K.
- BRIACELL THERAPEUTICS CORP. proceeds from grantors for the quarter ending 2026-01-31 was $733.82K.
| Period end | Proceeds from Grantors 3 month | Proceeds from Grantors 6 month | Proceeds from Grantors 9 month |
|---|---|---|---|
| 2026-04-30 | $110.20K 10-Q · filed 2026-06-09 | $844.02K derived: sum of 2 quarters · filed 2026-06-09 | $936.36K 10-Q · filed 2026-06-09 |
| 2026-01-31 | $733.82K 10-Q · filed 2026-03-10 | $826.16K 10-Q · filed 2026-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |